Capital Flow Monitor · Sponsors · CIK 1790169
ZeroStack Corp.
2626 COLE AVENUE, SUITE 300, DALLAS, TX, 75204 · 416-861-2267
Other Technology · Corporation· inc. TEXAS true 2026
Fit score
—
Offering
$1.0B
Sold
$1.0B
% sold
100.0%
Investors
2
Min investment
$5.0B
Exemption
506(b)
Filing history
| Filed | Form | Rule | Offering | Sold | % sold | Investors | |
|---|---|---|---|---|---|---|---|
| 2026-09-02 | D ·current | 506(b) | $1.0B | $1.0B | 100.0% | 2 | EDGAR ↗ |
| 2026-07-29 | D | 506(b) | $92.1M | $92.1M | 100.0% | 24 | EDGAR ↗ |
| 2025-10-10 | D | 506(b) | $25.2M | $25.2M | 100.0% | 18 | EDGAR ↗ |
| 2025-10-10 | D | 506(b) | $4.2M | $3.6M | 84.0% | 11 | EDGAR ↗ |
Related persons
Executive officers, directors and promoters, as filed. Other raises are matched by exact name and show amount sold as last reported.
-
Daniel Reis-Faria — Executive Officer / Director, Dallas, TX
1 other raise
- Texas Blocker Corp. $107.4M of $107.4M · 100.0%
-
Dany Vaiman — Executive Officer, Dallas, TX
1 other raise
- Texas Blocker Corp. $107.4M of $107.4M · 100.0%
- Rudy Rong — Executive Officer, Dallas, TX
- Michael Heinrich — Director, Dallas, TX
-
Edward Woo — Director, Dallas, TX
1 other raise
- Uvantis Therapeutics, Inc. $100K of $5.0M · 2.0%
- Manfred Leventhal — Director, Dallas, TX
- Laurence Zeifman — Director, Dallas, TX
Placement agents
- No sales compensation reported — direct raise.
Source: SEC EDGAR Form D. Self-reported by the issuer. Not investment advice.